Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxiredoxin 2 pseudogene 4 (PRDX2P4) is a human pseudogene located at 6q16[5]. As a pseudogene, it is a non-functional genetic sequence derived from the functional gene Peroxiredoxin 2 (PRDX2), an antioxidant enzyme involved in reducing hydrogen peroxide and organic hydroperoxides[3][8]. PRDX2P4 lacks the ability to encode a functional protein due to inactivating mutations or other disabling sequence characteristics common to pseudogenes[3]. It does not appear to have a direct biological or disease-related role, has no associated drugs, is not a therapeutic target, and serves primarily as a genomic relic of the PRDX2 gene[3][1][5]. There are no reported aliases or established functional roles for PRDX2P4 specifically. Key distinctions: - PRDX2P4 is different from "Peroxiredoxin 2" (PRDX2), which is an active enzyme involved in oxidative stress response. - As a pseudogene, PRDX2P4 is not transcribed into a functional protein and is not a druggable molecular target[1][3][5]. - No disease associations, biomarkers, or drug interactions are described for this pseudogene[1][5]. - The canonical PRDX2 gene has related pseudogenes on multiple chromosomes, but only the protein-coding PRDX2 gene (not the pseudogene) is functionally active and therapeutically relevant[4][6][8]. If you require structured information on the active protein (PRDX2) rather than this pseudogene, a separate entry should be prepared.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxiredoxin 2 pseudogene 4 (PRDX2P4).